nodes	percent_of_prediction	percent_of_DWPC	metapath
Bosutinib—CLK1—head—autistic disorder	0.000564	0.00134	CbGeAlD
Bosutinib—HCK—head—autistic disorder	0.000564	0.00134	CbGeAlD
Bosutinib—MAP2K5—telencephalon—autistic disorder	0.000562	0.00134	CbGeAlD
Bosutinib—BCR—nervous system—autistic disorder	0.00056	0.00133	CbGeAlD
Bosutinib—STK36—central nervous system—autistic disorder	0.00056	0.00133	CbGeAlD
Bosutinib—EPHB3—central nervous system—autistic disorder	0.00056	0.00133	CbGeAlD
Bosutinib—MAP3K12—nervous system—autistic disorder	0.000556	0.00132	CbGeAlD
Bosutinib—MERTK—central nervous system—autistic disorder	0.000553	0.00132	CbGeAlD
Bosutinib—PLK2—brain—autistic disorder	0.000553	0.00132	CbGeAlD
Bosutinib—BMP2K—head—autistic disorder	0.000553	0.00132	CbGeAlD
Bosutinib—CAMK2G—head—autistic disorder	0.000553	0.00132	CbGeAlD
Bosutinib—BMPR2—cerebellum—autistic disorder	0.000552	0.00131	CbGeAlD
Bosutinib—SIK3—brain—autistic disorder	0.00055	0.00131	CbGeAlD
Bosutinib—EPHB4—digestive system—autistic disorder	0.000549	0.00131	CbGeAlD
Bosutinib—CSF1R—telencephalon—autistic disorder	0.000549	0.00131	CbGeAlD
Bosutinib—LRRK2—head—autistic disorder	0.000548	0.00131	CbGeAlD
Bosutinib—STK36—cerebellum—autistic disorder	0.000547	0.0013	CbGeAlD
Bosutinib—EPHB3—cerebellum—autistic disorder	0.000547	0.0013	CbGeAlD
Bosutinib—MAP2K1—nervous system—autistic disorder	0.000545	0.0013	CbGeAlD
Bosutinib—STK35—nervous system—autistic disorder	0.000545	0.0013	CbGeAlD
Bosutinib—MAP4K4—central nervous system—autistic disorder	0.000543	0.00129	CbGeAlD
Bosutinib—CSK—nervous system—autistic disorder	0.000541	0.00129	CbGeAlD
Bosutinib—MERTK—cerebellum—autistic disorder	0.000541	0.00129	CbGeAlD
Bosutinib—BCR—central nervous system—autistic disorder	0.000539	0.00128	CbGeAlD
Bosutinib—EPHA2—digestive system—autistic disorder	0.000538	0.00128	CbGeAlD
Bosutinib—CSNK1A1—nervous system—autistic disorder	0.000538	0.00128	CbGeAlD
Bosutinib—FYN—digestive system—autistic disorder	0.000538	0.00128	CbGeAlD
Bosutinib—MAP3K12—central nervous system—autistic disorder	0.000535	0.00127	CbGeAlD
Bosutinib—HCK—nervous system—autistic disorder	0.000534	0.00127	CbGeAlD
Bosutinib—CLK1—nervous system—autistic disorder	0.000534	0.00127	CbGeAlD
Bosutinib—PTK2B—head—autistic disorder	0.000534	0.00127	CbGeAlD
Bosutinib—PDGFRB—eye—autistic disorder	0.000534	0.00127	CbGeAlD
Bosutinib—MAP4K4—cerebellum—autistic disorder	0.000531	0.00126	CbGeAlD
Bosutinib—STK4—brain—autistic disorder	0.000529	0.00126	CbGeAlD
Bosutinib—BCR—cerebellum—autistic disorder	0.000527	0.00125	CbGeAlD
Bosutinib—NUAK2—cerebellum—autistic disorder	0.000527	0.00125	CbGeAlD
Bosutinib—CSNK1E—head—autistic disorder	0.000526	0.00125	CbGeAlD
Bosutinib—STK35—central nervous system—autistic disorder	0.000525	0.00125	CbGeAlD
Bosutinib—MAP2K1—central nervous system—autistic disorder	0.000525	0.00125	CbGeAlD
Bosutinib—BMP2K—nervous system—autistic disorder	0.000524	0.00125	CbGeAlD
Bosutinib—CAMK2G—nervous system—autistic disorder	0.000524	0.00125	CbGeAlD
Bosutinib—MAP3K12—cerebellum—autistic disorder	0.000523	0.00125	CbGeAlD
Bosutinib—CAMK1D—brain—autistic disorder	0.000523	0.00124	CbGeAlD
Bosutinib—CSK—central nervous system—autistic disorder	0.000521	0.00124	CbGeAlD
Bosutinib—LRRK2—nervous system—autistic disorder	0.00052	0.00124	CbGeAlD
Bosutinib—CSNK1A1—central nervous system—autistic disorder	0.000518	0.00123	CbGeAlD
Bosutinib—SIK1—head—autistic disorder	0.000517	0.00123	CbGeAlD
Bosutinib—IRAK4—head—autistic disorder	0.000517	0.00123	CbGeAlD
Bosutinib—STK24—brain—autistic disorder	0.000517	0.00123	CbGeAlD
Bosutinib—HCK—central nervous system—autistic disorder	0.000514	0.00122	CbGeAlD
Bosutinib—CLK1—central nervous system—autistic disorder	0.000514	0.00122	CbGeAlD
Bosutinib—MAP2K1—cerebellum—autistic disorder	0.000513	0.00122	CbGeAlD
Bosutinib—STK35—cerebellum—autistic disorder	0.000513	0.00122	CbGeAlD
Bosutinib—EPHA4—head—autistic disorder	0.000512	0.00122	CbGeAlD
Bosutinib—CSK—cerebellum—autistic disorder	0.000509	0.00121	CbGeAlD
Bosutinib—ERBB3—head—autistic disorder	0.000507	0.00121	CbGeAlD
Bosutinib—PTK2B—nervous system—autistic disorder	0.000507	0.00121	CbGeAlD
Bosutinib—CSNK1A1—cerebellum—autistic disorder	0.000506	0.0012	CbGeAlD
Bosutinib—MAP2K2—head—autistic disorder	0.000506	0.0012	CbGeAlD
Bosutinib—ULK3—head—autistic disorder	0.000506	0.0012	CbGeAlD
Bosutinib—CAMK2G—central nervous system—autistic disorder	0.000505	0.0012	CbGeAlD
Bosutinib—BMP2K—central nervous system—autistic disorder	0.000505	0.0012	CbGeAlD
Bosutinib—CLK1—cerebellum—autistic disorder	0.000503	0.0012	CbGeAlD
Bosutinib—MAP3K2—head—autistic disorder	0.000502	0.0012	CbGeAlD
Bosutinib—LRRK2—central nervous system—autistic disorder	0.0005	0.00119	CbGeAlD
Bosutinib—FER—brain—autistic disorder	0.0005	0.00119	CbGeAlD
Bosutinib—EPHA5—brain—autistic disorder	0.0005	0.00119	CbGeAlD
Bosutinib—TYRO3—brain—autistic disorder	0.0005	0.00119	CbGeAlD
Bosutinib—ALK—brain—autistic disorder	0.0005	0.00119	CbGeAlD
Bosutinib—ABL2—cerebellum—autistic disorder	0.0005	0.00119	CbGeAlD
Bosutinib—CSNK1E—nervous system—autistic disorder	0.000498	0.00119	CbGeAlD
Bosutinib—LYN—brain—autistic disorder	0.000497	0.00118	CbGeAlD
Bosutinib—CAMK2G—cerebellum—autistic disorder	0.000494	0.00117	CbGeAlD
Bosutinib—BMP2K—cerebellum—autistic disorder	0.000494	0.00117	CbGeAlD
Bosutinib—PTK2—head—autistic disorder	0.000492	0.00117	CbGeAlD
Bosutinib—TBK1—head—autistic disorder	0.000492	0.00117	CbGeAlD
Bosutinib—IRAK4—nervous system—autistic disorder	0.000491	0.00117	CbGeAlD
Bosutinib—SIK1—nervous system—autistic disorder	0.000491	0.00117	CbGeAlD
Bosutinib—MAP4K1—brain—autistic disorder	0.00049	0.00117	CbGeAlD
Bosutinib—MAP3K19—brain—autistic disorder	0.00049	0.00117	CbGeAlD
Bosutinib—LRRK2—cerebellum—autistic disorder	0.000489	0.00116	CbGeAlD
Bosutinib—ABL1—brainstem—autistic disorder	0.000489	0.00116	CbGeAlD
Bosutinib—EGFR—cerebellum—autistic disorder	0.000488	0.00116	CbGeAlD
Bosutinib—PTK2B—central nervous system—autistic disorder	0.000488	0.00116	CbGeAlD
Bosutinib—BTK—brain—autistic disorder	0.000487	0.00116	CbGeAlD
Bosutinib—PDGFRB—telencephalon—autistic disorder	0.000487	0.00116	CbGeAlD
Bosutinib—EPHA4—nervous system—autistic disorder	0.000486	0.00116	CbGeAlD
Bosutinib—YES1—digestive system—autistic disorder	0.000485	0.00115	CbGeAlD
Bosutinib—ERBB3—nervous system—autistic disorder	0.000481	0.00114	CbGeAlD
Bosutinib—STK10—digestive system—autistic disorder	0.000481	0.00114	CbGeAlD
Bosutinib—TNK2—brain—autistic disorder	0.00048	0.00114	CbGeAlD
Bosutinib—CSNK1E—central nervous system—autistic disorder	0.00048	0.00114	CbGeAlD
Bosutinib—ULK3—nervous system—autistic disorder	0.00048	0.00114	CbGeAlD
Bosutinib—MAP2K2—nervous system—autistic disorder	0.00048	0.00114	CbGeAlD
Bosutinib—TAOK3—digestive system—autistic disorder	0.000479	0.00114	CbGeAlD
Bosutinib—PTK2B—cerebellum—autistic disorder	0.000477	0.00113	CbGeAlD
Bosutinib—MAP3K2—nervous system—autistic disorder	0.000476	0.00113	CbGeAlD
Bosutinib—ABL1—eye—autistic disorder	0.000476	0.00113	CbGeAlD
Bosutinib—MAP4K2—brain—autistic disorder	0.000474	0.00113	CbGeAlD
Bosutinib—RPS6KB1—head—autistic disorder	0.000473	0.00113	CbGeAlD
Bosutinib—SIK1—central nervous system—autistic disorder	0.000472	0.00112	CbGeAlD
Bosutinib—IRAK4—central nervous system—autistic disorder	0.000472	0.00112	CbGeAlD
Bosutinib—FGR—head—autistic disorder	0.00047	0.00112	CbGeAlD
Bosutinib—CSNK1E—cerebellum—autistic disorder	0.000469	0.00112	CbGeAlD
Bosutinib—AXL—head—autistic disorder	0.000469	0.00112	CbGeAlD
Bosutinib—EPHA4—central nervous system—autistic disorder	0.000468	0.00111	CbGeAlD
Bosutinib—ERBB4—brain—autistic disorder	0.000467	0.00111	CbGeAlD
Bosutinib—STK3—brain—autistic disorder	0.000467	0.00111	CbGeAlD
Bosutinib—SRC—digestive system—autistic disorder	0.000467	0.00111	CbGeAlD
Bosutinib—TBK1—nervous system—autistic disorder	0.000466	0.00111	CbGeAlD
Bosutinib—PTK2—nervous system—autistic disorder	0.000466	0.00111	CbGeAlD
Bosutinib—ERBB3—central nervous system—autistic disorder	0.000463	0.0011	CbGeAlD
Bosutinib—ULK3—central nervous system—autistic disorder	0.000462	0.0011	CbGeAlD
Bosutinib—MAP2K2—central nervous system—autistic disorder	0.000462	0.0011	CbGeAlD
Bosutinib—IRAK4—cerebellum—autistic disorder	0.000462	0.0011	CbGeAlD
Bosutinib—SIK1—cerebellum—autistic disorder	0.000462	0.0011	CbGeAlD
Bosutinib—ROCK1—brain—autistic disorder	0.000461	0.0011	CbGeAlD
Bosutinib—MAP3K2—central nervous system—autistic disorder	0.000459	0.00109	CbGeAlD
Bosutinib—EPHA4—cerebellum—autistic disorder	0.000457	0.00109	CbGeAlD
Bosutinib—ERBB3—cerebellum—autistic disorder	0.000453	0.00108	CbGeAlD
Bosutinib—ULK3—cerebellum—autistic disorder	0.000451	0.00107	CbGeAlD
Bosutinib—MAP2K2—cerebellum—autistic disorder	0.000451	0.00107	CbGeAlD
Bosutinib—TBK1—central nervous system—autistic disorder	0.000449	0.00107	CbGeAlD
Bosutinib—PTK2—central nervous system—autistic disorder	0.000449	0.00107	CbGeAlD
Bosutinib—RPS6KB1—nervous system—autistic disorder	0.000449	0.00107	CbGeAlD
Bosutinib—MAP3K2—cerebellum—autistic disorder	0.000448	0.00107	CbGeAlD
Bosutinib—BMPR2—brain—autistic disorder	0.000448	0.00107	CbGeAlD
Bosutinib—FGR—nervous system—autistic disorder	0.000446	0.00106	CbGeAlD
Bosutinib—STK36—brain—autistic disorder	0.000444	0.00106	CbGeAlD
Bosutinib—EPHB3—brain—autistic disorder	0.000444	0.00106	CbGeAlD
Bosutinib—AXL—nervous system—autistic disorder	0.000444	0.00106	CbGeAlD
Bosutinib—MAP3K7—cerebellum—autistic disorder	0.000444	0.00106	CbGeAlD
Bosutinib—MERTK—brain—autistic disorder	0.000439	0.00105	CbGeAlD
Bosutinib—EPHA2—head—autistic disorder	0.000439	0.00105	CbGeAlD
Bosutinib—PTK2—cerebellum—autistic disorder	0.000439	0.00104	CbGeAlD
Bosutinib—TBK1—cerebellum—autistic disorder	0.000439	0.00104	CbGeAlD
Bosutinib—FYN—head—autistic disorder	0.000438	0.00104	CbGeAlD
Bosutinib—ABL1—telencephalon—autistic disorder	0.000434	0.00103	CbGeAlD
Bosutinib—RPS6KB1—central nervous system—autistic disorder	0.000432	0.00103	CbGeAlD
Bosutinib—MAP4K4—brain—autistic disorder	0.000431	0.00103	CbGeAlD
Bosutinib—IRAK1—cerebellum—autistic disorder	0.00043	0.00102	CbGeAlD
Bosutinib—FGR—central nervous system—autistic disorder	0.000429	0.00102	CbGeAlD
Bosutinib—MAP4K5—head—autistic disorder	0.000428	0.00102	CbGeAlD
Bosutinib—MAP3K3—head—autistic disorder	0.000428	0.00102	CbGeAlD
Bosutinib—BCR—brain—autistic disorder	0.000428	0.00102	CbGeAlD
Bosutinib—NUAK2—brain—autistic disorder	0.000428	0.00102	CbGeAlD
Bosutinib—AXL—central nervous system—autistic disorder	0.000428	0.00102	CbGeAlD
Bosutinib—MAP3K12—brain—autistic disorder	0.000425	0.00101	CbGeAlD
Bosutinib—RPS6KB1—cerebellum—autistic disorder	0.000422	0.00101	CbGeAlD
Bosutinib—CSF1R—digestive system—autistic disorder	0.000419	0.000997	CbGeAlD
Bosutinib—AXL—cerebellum—autistic disorder	0.000418	0.000995	CbGeAlD
Bosutinib—MAP2K1—brain—autistic disorder	0.000416	0.000991	CbGeAlD
Bosutinib—STK35—brain—autistic disorder	0.000416	0.000991	CbGeAlD
Bosutinib—EPHA2—nervous system—autistic disorder	0.000416	0.000991	CbGeAlD
Bosutinib—FYN—nervous system—autistic disorder	0.000416	0.00099	CbGeAlD
Bosutinib—CSK—brain—autistic disorder	0.000414	0.000985	CbGeAlD
Bosutinib—CSNK1A1—brain—autistic disorder	0.000411	0.000978	CbGeAlD
Bosutinib—HCK—brain—autistic disorder	0.000408	0.000972	CbGeAlD
Bosutinib—CLK1—brain—autistic disorder	0.000408	0.000972	CbGeAlD
Bosutinib—MAP4K5—nervous system—autistic disorder	0.000406	0.000967	CbGeAlD
Bosutinib—MAP3K3—nervous system—autistic disorder	0.000406	0.000967	CbGeAlD
Bosutinib—ABL2—brain—autistic disorder	0.000406	0.000966	CbGeAlD
Bosutinib—SLK—cerebellum—autistic disorder	0.000402	0.000958	CbGeAlD
Bosutinib—EPHA2—central nervous system—autistic disorder	0.000401	0.000954	CbGeAlD
Bosutinib—CAMK2G—brain—autistic disorder	0.000401	0.000954	CbGeAlD
Bosutinib—BMP2K—brain—autistic disorder	0.000401	0.000954	CbGeAlD
Bosutinib—FYN—central nervous system—autistic disorder	0.0004	0.000953	CbGeAlD
Bosutinib—EPHB4—cerebellum—autistic disorder	0.000399	0.000951	CbGeAlD
Bosutinib—LRRK2—brain—autistic disorder	0.000397	0.000946	CbGeAlD
Bosutinib—EGFR—brain—autistic disorder	0.000396	0.000943	CbGeAlD
Bosutinib—YES1—head—autistic disorder	0.000396	0.000942	CbGeAlD
Bosutinib—STK10—head—autistic disorder	0.000392	0.000933	CbGeAlD
Bosutinib—FYN—cerebellum—autistic disorder	0.000391	0.000931	CbGeAlD
Bosutinib—MAP4K5—central nervous system—autistic disorder	0.000391	0.000931	CbGeAlD
Bosutinib—MAP3K3—central nervous system—autistic disorder	0.000391	0.000931	CbGeAlD
Bosutinib—TAOK3—head—autistic disorder	0.000391	0.00093	CbGeAlD
Bosutinib—PTK2B—brain—autistic disorder	0.000387	0.000922	CbGeAlD
Bosutinib—MAP4K5—cerebellum—autistic disorder	0.000382	0.00091	CbGeAlD
Bosutinib—MAP3K3—cerebellum—autistic disorder	0.000382	0.00091	CbGeAlD
Bosutinib—CSNK1E—brain—autistic disorder	0.000381	0.000907	CbGeAlD
Bosutinib—SRC—head—autistic disorder	0.000381	0.000906	CbGeAlD
Bosutinib—YES1—nervous system—autistic disorder	0.000375	0.000893	CbGeAlD
Bosutinib—SIK1—brain—autistic disorder	0.000375	0.000893	CbGeAlD
Bosutinib—IRAK4—brain—autistic disorder	0.000375	0.000893	CbGeAlD
Bosutinib—STK10—nervous system—autistic disorder	0.000372	0.000885	CbGeAlD
Bosutinib—PDGFRB—digestive system—autistic disorder	0.000372	0.000884	CbGeAlD
Bosutinib—EPHA4—brain—autistic disorder	0.000371	0.000884	CbGeAlD
Bosutinib—TAOK3—nervous system—autistic disorder	0.00037	0.000882	CbGeAlD
Bosutinib—ERBB3—brain—autistic disorder	0.000368	0.000875	CbGeAlD
Bosutinib—MAP2K2—brain—autistic disorder	0.000367	0.000873	CbGeAlD
Bosutinib—ULK3—brain—autistic disorder	0.000367	0.000873	CbGeAlD
Bosutinib—MAP3K2—brain—autistic disorder	0.000364	0.000866	CbGeAlD
Bosutinib—YES1—central nervous system—autistic disorder	0.000361	0.00086	CbGeAlD
Bosutinib—SRC—nervous system—autistic disorder	0.000361	0.000859	CbGeAlD
Bosutinib—MAP3K7—brain—autistic disorder	0.000361	0.000858	CbGeAlD
Bosutinib—STK10—central nervous system—autistic disorder	0.000358	0.000852	CbGeAlD
Bosutinib—TAOK3—central nervous system—autistic disorder	0.000357	0.000849	CbGeAlD
Bosutinib—PTK2—brain—autistic disorder	0.000357	0.000849	CbGeAlD
Bosutinib—TBK1—brain—autistic disorder	0.000357	0.000849	CbGeAlD
Bosutinib—YES1—cerebellum—autistic disorder	0.000353	0.00084	CbGeAlD
Bosutinib—MAP2K5—head—autistic disorder	0.00035	0.000834	CbGeAlD
Bosutinib—STK10—cerebellum—autistic disorder	0.00035	0.000833	CbGeAlD
Bosutinib—IRAK1—brain—autistic disorder	0.00035	0.000832	CbGeAlD
Bosutinib—TAOK3—cerebellum—autistic disorder	0.000349	0.00083	CbGeAlD
Bosutinib—SRC—central nervous system—autistic disorder	0.000348	0.000827	CbGeAlD
Bosutinib—RPS6KB1—brain—autistic disorder	0.000343	0.000816	CbGeAlD
Bosutinib—CSF1R—head—autistic disorder	0.000342	0.000814	CbGeAlD
Bosutinib—FGR—brain—autistic disorder	0.000341	0.000811	CbGeAlD
Bosutinib—SRC—cerebellum—autistic disorder	0.00034	0.000808	CbGeAlD
Bosutinib—AXL—brain—autistic disorder	0.00034	0.000808	CbGeAlD
Bosutinib—MAP2K5—nervous system—autistic disorder	0.000332	0.00079	CbGeAlD
Bosutinib—ABL1—digestive system—autistic disorder	0.000331	0.000788	CbGeAlD
Bosutinib—SLK—brain—autistic disorder	0.000327	0.000778	CbGeAlD
Bosutinib—EPHB4—brain—autistic disorder	0.000324	0.000772	CbGeAlD
Bosutinib—CSF1R—nervous system—autistic disorder	0.000324	0.000771	CbGeAlD
Bosutinib—MAP2K5—central nervous system—autistic disorder	0.00032	0.000761	CbGeAlD
Bosutinib—EPHA2—brain—autistic disorder	0.000318	0.000758	CbGeAlD
Bosutinib—FYN—brain—autistic disorder	0.000318	0.000756	CbGeAlD
Bosutinib—MAP2K5—cerebellum—autistic disorder	0.000312	0.000744	CbGeAlD
Bosutinib—CSF1R—central nervous system—autistic disorder	0.000312	0.000743	CbGeAlD
Bosutinib—MAP3K3—brain—autistic disorder	0.000311	0.000739	CbGeAlD
Bosutinib—MAP4K5—brain—autistic disorder	0.000311	0.000739	CbGeAlD
Bosutinib—CSF1R—cerebellum—autistic disorder	0.000305	0.000726	CbGeAlD
Bosutinib—PDGFRB—head—autistic disorder	0.000303	0.000721	CbGeAlD
Bosutinib—PDGFRB—nervous system—autistic disorder	0.000287	0.000684	CbGeAlD
Bosutinib—YES1—brain—autistic disorder	0.000287	0.000683	CbGeAlD
Bosutinib—STK10—brain—autistic disorder	0.000284	0.000676	CbGeAlD
Bosutinib—TAOK3—brain—autistic disorder	0.000283	0.000674	CbGeAlD
Bosutinib—PDGFRB—central nervous system—autistic disorder	0.000277	0.000659	CbGeAlD
Bosutinib—SRC—brain—autistic disorder	0.000276	0.000657	CbGeAlD
Bosutinib—PDGFRB—cerebellum—autistic disorder	0.00027	0.000644	CbGeAlD
Bosutinib—ABL1—head—autistic disorder	0.00027	0.000643	CbGeAlD
Bosutinib—ABL1—nervous system—autistic disorder	0.000256	0.00061	CbGeAlD
Bosutinib—MAP2K5—brain—autistic disorder	0.000254	0.000604	CbGeAlD
Bosutinib—CSF1R—brain—autistic disorder	0.000248	0.00059	CbGeAlD
Bosutinib—ABL1—central nervous system—autistic disorder	0.000247	0.000587	CbGeAlD
Bosutinib—ABL1—cerebellum—autistic disorder	0.000241	0.000574	CbGeAlD
Bosutinib—PDGFRB—brain—autistic disorder	0.00022	0.000523	CbGeAlD
Bosutinib—ABL1—brain—autistic disorder	0.000196	0.000466	CbGeAlD
Bosutinib—ABCB1—forebrain—autistic disorder	0.000147	0.000349	CbGeAlD
Bosutinib—CYP3A4—digestive system—autistic disorder	0.000145	0.000346	CbGeAlD
Bosutinib—ABCB1—telencephalon—autistic disorder	0.000135	0.000321	CbGeAlD
Bosutinib—CYP3A4—nervous system—autistic disorder	0.000113	0.000268	CbGeAlD
Bosutinib—CYP3A4—central nervous system—autistic disorder	0.000108	0.000258	CbGeAlD
Bosutinib—ABCB1—digestive system—autistic disorder	0.000103	0.000245	CbGeAlD
Bosutinib—ABCB1—head—autistic disorder	8.4e-05	0.0002	CbGeAlD
Bosutinib—ABCB1—nervous system—autistic disorder	7.97e-05	0.00019	CbGeAlD
Bosutinib—ABCB1—central nervous system—autistic disorder	7.67e-05	0.000183	CbGeAlD
Bosutinib—ABCB1—cerebellum—autistic disorder	7.5e-05	0.000178	CbGeAlD
Bosutinib—ABCB1—brain—autistic disorder	6.09e-05	0.000145	CbGeAlD
Bosutinib—SRC—Signaling Pathways—MEF2C—autistic disorder	2.84e-06	4.9e-06	CbGpPWpGaD
Bosutinib—YES1—Signaling Pathways—IL2—autistic disorder	2.82e-06	4.87e-06	CbGpPWpGaD
Bosutinib—SRC—Developmental Biology—HRAS—autistic disorder	2.82e-06	4.86e-06	CbGpPWpGaD
Bosutinib—ERBB3—Disease—HRAS—autistic disorder	2.82e-06	4.86e-06	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—LEP—autistic disorder	2.82e-06	4.86e-06	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—APOE—autistic disorder	2.82e-06	4.86e-06	CbGpPWpGaD
Bosutinib—LCK—Innate Immune System—HRAS—autistic disorder	2.81e-06	4.85e-06	CbGpPWpGaD
Bosutinib—EGFR—Adaptive Immune System—HRAS—autistic disorder	2.8e-06	4.83e-06	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—POMC—autistic disorder	2.8e-06	4.83e-06	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—IGF1—autistic disorder	2.8e-06	4.82e-06	CbGpPWpGaD
Bosutinib—EGFR—Innate Immune System—IL6—autistic disorder	2.79e-06	4.82e-06	CbGpPWpGaD
Bosutinib—ERBB4—Signaling Pathways—MAPK1—autistic disorder	2.79e-06	4.81e-06	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—POMC—autistic disorder	2.79e-06	4.81e-06	CbGpPWpGaD
Bosutinib—FYN—Disease—PTEN—autistic disorder	2.78e-06	4.8e-06	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—TSC2—autistic disorder	2.78e-06	4.79e-06	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—ITGB3—autistic disorder	2.77e-06	4.78e-06	CbGpPWpGaD
Bosutinib—MAP2K1—Disease—PTEN—autistic disorder	2.77e-06	4.78e-06	CbGpPWpGaD
Bosutinib—EGFR—Immune System—IL2—autistic disorder	2.77e-06	4.77e-06	CbGpPWpGaD
Bosutinib—SRC—Hemostasis—HRAS—autistic disorder	2.77e-06	4.77e-06	CbGpPWpGaD
Bosutinib—EGFR—Disease—PTGS2—autistic disorder	2.76e-06	4.76e-06	CbGpPWpGaD
Bosutinib—PTK2B—Signaling Pathways—MAPK1—autistic disorder	2.75e-06	4.74e-06	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—IGF1—autistic disorder	2.74e-06	4.72e-06	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling Pathways—SERPINE1—autistic disorder	2.72e-06	4.69e-06	CbGpPWpGaD
Bosutinib—PTK2—Immune System—HRAS—autistic disorder	2.72e-06	4.69e-06	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—APOE—autistic disorder	2.72e-06	4.68e-06	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—LEP—autistic disorder	2.72e-06	4.68e-06	CbGpPWpGaD
Bosutinib—LCK—Adaptive Immune System—HRAS—autistic disorder	2.7e-06	4.66e-06	CbGpPWpGaD
Bosutinib—SRC—Developmental Biology—IL6—autistic disorder	2.7e-06	4.65e-06	CbGpPWpGaD
Bosutinib—ERBB3—Disease—IL6—autistic disorder	2.7e-06	4.65e-06	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—IGF1—autistic disorder	2.7e-06	4.65e-06	CbGpPWpGaD
Bosutinib—SRC—Disease—SERPINE1—autistic disorder	2.69e-06	4.65e-06	CbGpPWpGaD
Bosutinib—PTK2—Signaling Pathways—PTEN—autistic disorder	2.69e-06	4.64e-06	CbGpPWpGaD
Bosutinib—LCK—Innate Immune System—IL6—autistic disorder	2.69e-06	4.64e-06	CbGpPWpGaD
Bosutinib—SRC—Immune System—BCL2—autistic disorder	2.68e-06	4.63e-06	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—IGF1—autistic disorder	2.68e-06	4.62e-06	CbGpPWpGaD
Bosutinib—YES1—Immune System—HRAS—autistic disorder	2.68e-06	4.62e-06	CbGpPWpGaD
Bosutinib—IRAK1—Signaling Pathways—IL2—autistic disorder	2.68e-06	4.62e-06	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling by GPCR—MAPK1—autistic disorder	2.67e-06	4.6e-06	CbGpPWpGaD
Bosutinib—LCK—Immune System—IL2—autistic disorder	2.67e-06	4.6e-06	CbGpPWpGaD
Bosutinib—SRC—Immune System—IFNG—autistic disorder	2.66e-06	4.58e-06	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—PRKCB—autistic disorder	2.66e-06	4.58e-06	CbGpPWpGaD
Bosutinib—LCK—Disease—PTGS2—autistic disorder	2.66e-06	4.58e-06	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—SERPINE1—autistic disorder	2.66e-06	4.58e-06	CbGpPWpGaD
Bosutinib—YES1—Signaling Pathways—PTEN—autistic disorder	2.66e-06	4.58e-06	CbGpPWpGaD
Bosutinib—ROCK1—Signaling Pathways—MAPK1—autistic disorder	2.65e-06	4.57e-06	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—RORA—autistic disorder	2.64e-06	4.55e-06	CbGpPWpGaD
Bosutinib—MAP2K2—Immune System—MAPK1—autistic disorder	2.61e-06	4.49e-06	CbGpPWpGaD
Bosutinib—EGFR—Immune System—PTEN—autistic disorder	2.61e-06	4.49e-06	CbGpPWpGaD
Bosutinib—PTK2—Immune System—IL6—autistic disorder	2.6e-06	4.49e-06	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—SERPINE1—autistic disorder	2.6e-06	4.48e-06	CbGpPWpGaD
Bosutinib—CSNK1E—Signaling Pathways—HRAS—autistic disorder	2.59e-06	4.47e-06	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—HTR2A—autistic disorder	2.59e-06	4.46e-06	CbGpPWpGaD
Bosutinib—YES1—Immune System—IL6—autistic disorder	2.57e-06	4.43e-06	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—PRKCB—autistic disorder	2.56e-06	4.42e-06	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—SERPINE1—autistic disorder	2.56e-06	4.42e-06	CbGpPWpGaD
Bosutinib—RPS6KB1—Signaling Pathways—MAPK1—autistic disorder	2.55e-06	4.4e-06	CbGpPWpGaD
Bosutinib—MAP2K5—Signaling Pathways—MAPK1—autistic disorder	2.55e-06	4.4e-06	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—SERPINE1—autistic disorder	2.55e-06	4.39e-06	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—APC—autistic disorder	2.54e-06	4.39e-06	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—PIK3CG—autistic disorder	2.54e-06	4.39e-06	CbGpPWpGaD
Bosutinib—PDGFRB—Immune System—MAPK1—autistic disorder	2.54e-06	4.39e-06	CbGpPWpGaD
Bosutinib—IRAK1—Immune System—HRAS—autistic disorder	2.54e-06	4.39e-06	CbGpPWpGaD
Bosutinib—MAP3K7—Signaling Pathways—IL2—autistic disorder	2.52e-06	4.35e-06	CbGpPWpGaD
Bosutinib—IRAK1—Signaling Pathways—PTEN—autistic disorder	2.52e-06	4.34e-06	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—EGF—autistic disorder	2.51e-06	4.34e-06	CbGpPWpGaD
Bosutinib—LCK—Immune System—PTEN—autistic disorder	2.51e-06	4.33e-06	CbGpPWpGaD
Bosutinib—SRC—Innate Immune System—HRAS—autistic disorder	2.49e-06	4.3e-06	CbGpPWpGaD
Bosutinib—LYN—Immune System—MAPK1—autistic disorder	2.49e-06	4.29e-06	CbGpPWpGaD
Bosutinib—CSNK1E—Signaling Pathways—IL6—autistic disorder	2.48e-06	4.28e-06	CbGpPWpGaD
Bosutinib—ABL1—Immune System—MAPK1—autistic disorder	2.48e-06	4.27e-06	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—MAOB—autistic disorder	2.47e-06	4.27e-06	CbGpPWpGaD
Bosutinib—ERBB3—Signaling Pathways—MAPK1—autistic disorder	2.46e-06	4.24e-06	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—TSC2—autistic disorder	2.46e-06	4.24e-06	CbGpPWpGaD
Bosutinib—FYN—Immune System—MAPK1—autistic disorder	2.45e-06	4.23e-06	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—PIK3CG—autistic disorder	2.45e-06	4.23e-06	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—APC—autistic disorder	2.45e-06	4.23e-06	CbGpPWpGaD
Bosutinib—MAP2K1—Immune System—MAPK1—autistic disorder	2.44e-06	4.21e-06	CbGpPWpGaD
Bosutinib—IRAK1—Immune System—IL6—autistic disorder	2.43e-06	4.2e-06	CbGpPWpGaD
Bosutinib—ABCB1—Metabolism—CYP19A1—autistic disorder	2.43e-06	4.19e-06	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—EGF—autistic disorder	2.42e-06	4.18e-06	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—POMC—autistic disorder	2.42e-06	4.18e-06	CbGpPWpGaD
Bosutinib—MAP2K2—Disease—MAPK1—autistic disorder	2.41e-06	4.15e-06	CbGpPWpGaD
Bosutinib—EGFR—Disease—PTEN—autistic disorder	2.41e-06	4.15e-06	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—LEP—autistic disorder	2.4e-06	4.15e-06	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—APOE—autistic disorder	2.4e-06	4.15e-06	CbGpPWpGaD
Bosutinib—MAP3K7—Immune System—HRAS—autistic disorder	2.39e-06	4.13e-06	CbGpPWpGaD
Bosutinib—SRC—Adaptive Immune System—HRAS—autistic disorder	2.39e-06	4.12e-06	CbGpPWpGaD
Bosutinib—SRC—Innate Immune System—IL6—autistic disorder	2.38e-06	4.11e-06	CbGpPWpGaD
Bosutinib—MAP3K7—Signaling Pathways—PTEN—autistic disorder	2.37e-06	4.09e-06	CbGpPWpGaD
Bosutinib—SRC—Immune System—IL2—autistic disorder	2.36e-06	4.07e-06	CbGpPWpGaD
Bosutinib—SRC—Disease—PTGS2—autistic disorder	2.35e-06	4.06e-06	CbGpPWpGaD
Bosutinib—PDGFRB—Disease—MAPK1—autistic disorder	2.35e-06	4.05e-06	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—POMC—autistic disorder	2.33e-06	4.02e-06	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—IGF1—autistic disorder	2.33e-06	4.02e-06	CbGpPWpGaD
Bosutinib—EGFR—Signaling by GPCR—MAPK1—autistic disorder	2.32e-06	4e-06	CbGpPWpGaD
Bosutinib—LCK—Disease—PTEN—autistic disorder	2.32e-06	4e-06	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—TPH2—autistic disorder	2.3e-06	3.97e-06	CbGpPWpGaD
Bosutinib—MAP3K7—Immune System—IL6—autistic disorder	2.29e-06	3.95e-06	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling by GPCR—HRAS—autistic disorder	2.29e-06	3.95e-06	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—PRKCB—autistic disorder	2.27e-06	3.91e-06	CbGpPWpGaD
Bosutinib—FYN—Disease—MAPK1—autistic disorder	2.26e-06	3.9e-06	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—DPYD—autistic disorder	2.26e-06	3.9e-06	CbGpPWpGaD
Bosutinib—ABCB1—Metabolism—COMT—autistic disorder	2.26e-06	3.9e-06	CbGpPWpGaD
Bosutinib—MAP2K1—Disease—MAPK1—autistic disorder	2.25e-06	3.88e-06	CbGpPWpGaD
Bosutinib—ABCB1—Metabolism—GSTP1—autistic disorder	2.25e-06	3.88e-06	CbGpPWpGaD
Bosutinib—ABCB1—Metabolism—MAOA—autistic disorder	2.25e-06	3.87e-06	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—IGF1—autistic disorder	2.24e-06	3.87e-06	CbGpPWpGaD
Bosutinib—ERBB4—Signaling Pathways—HRAS—autistic disorder	2.24e-06	3.86e-06	CbGpPWpGaD
Bosutinib—SRC—Immune System—PTEN—autistic disorder	2.22e-06	3.83e-06	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—SERPINE1—autistic disorder	2.21e-06	3.81e-06	CbGpPWpGaD
Bosutinib—PTK2B—Signaling Pathways—HRAS—autistic disorder	2.21e-06	3.81e-06	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling Pathways—IL2—autistic disorder	2.2e-06	3.8e-06	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling by GPCR—IL6—autistic disorder	2.19e-06	3.78e-06	CbGpPWpGaD
Bosutinib—ABCB1—Metabolism—CAT—autistic disorder	2.19e-06	3.78e-06	CbGpPWpGaD
Bosutinib—PTK2—Signaling Pathways—MAPK1—autistic disorder	2.19e-06	3.78e-06	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—APC—autistic disorder	2.17e-06	3.74e-06	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—PIK3CG—autistic disorder	2.17e-06	3.74e-06	CbGpPWpGaD
Bosutinib—YES1—Signaling Pathways—MAPK1—autistic disorder	2.16e-06	3.72e-06	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—IL2—autistic disorder	2.15e-06	3.71e-06	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—EGF—autistic disorder	2.15e-06	3.7e-06	CbGpPWpGaD
Bosutinib—ERBB4—Signaling Pathways—IL6—autistic disorder	2.14e-06	3.7e-06	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling by GPCR—HRAS—autistic disorder	2.14e-06	3.69e-06	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—SERPINE1—autistic disorder	2.13e-06	3.68e-06	CbGpPWpGaD
Bosutinib—ROCK1—Signaling Pathways—HRAS—autistic disorder	2.13e-06	3.67e-06	CbGpPWpGaD
Bosutinib—EGFR—Immune System—MAPK1—autistic disorder	2.12e-06	3.65e-06	CbGpPWpGaD
Bosutinib—PTK2B—Signaling Pathways—IL6—autistic disorder	2.11e-06	3.64e-06	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—IL2—autistic disorder	2.1e-06	3.63e-06	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—CACNA1C—autistic disorder	2.1e-06	3.63e-06	CbGpPWpGaD
Bosutinib—MAP2K2—Immune System—HRAS—autistic disorder	2.09e-06	3.61e-06	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling Pathways—PTEN—autistic disorder	2.07e-06	3.57e-06	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—IL2—autistic disorder	2.07e-06	3.57e-06	CbGpPWpGaD
Bosutinib—ABCB1—Metabolism—PLA2G4A—autistic disorder	2.07e-06	3.57e-06	CbGpPWpGaD
Bosutinib—ABCB1—Metabolism—GSTM1—autistic disorder	2.07e-06	3.57e-06	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—POMC—autistic disorder	2.07e-06	3.56e-06	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—IL2—autistic disorder	2.06e-06	3.55e-06	CbGpPWpGaD
Bosutinib—SRC—Disease—PTEN—autistic disorder	2.05e-06	3.54e-06	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling by GPCR—IL6—autistic disorder	2.05e-06	3.54e-06	CbGpPWpGaD
Bosutinib—MAP2K5—Signaling Pathways—HRAS—autistic disorder	2.05e-06	3.53e-06	CbGpPWpGaD
Bosutinib—RPS6KB1—Signaling Pathways—HRAS—autistic disorder	2.05e-06	3.53e-06	CbGpPWpGaD
Bosutinib—IRAK1—Signaling Pathways—MAPK1—autistic disorder	2.05e-06	3.53e-06	CbGpPWpGaD
Bosutinib—PDGFRB—Immune System—HRAS—autistic disorder	2.04e-06	3.52e-06	CbGpPWpGaD
Bosutinib—LCK—Immune System—MAPK1—autistic disorder	2.04e-06	3.52e-06	CbGpPWpGaD
Bosutinib—ROCK1—Signaling Pathways—IL6—autistic disorder	2.04e-06	3.51e-06	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—PTEN—autistic disorder	2.02e-06	3.49e-06	CbGpPWpGaD
Bosutinib—MAP2K2—Immune System—IL6—autistic disorder	2e-06	3.45e-06	CbGpPWpGaD
Bosutinib—LYN—Immune System—HRAS—autistic disorder	2e-06	3.45e-06	CbGpPWpGaD
Bosutinib—ABL1—Immune System—HRAS—autistic disorder	1.99e-06	3.43e-06	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—IGF1—autistic disorder	1.99e-06	3.43e-06	CbGpPWpGaD
Bosutinib—ABCB1—Metabolism—GPX1—autistic disorder	1.98e-06	3.42e-06	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—PTEN—autistic disorder	1.98e-06	3.42e-06	CbGpPWpGaD
Bosutinib—ERBB3—Signaling Pathways—HRAS—autistic disorder	1.97e-06	3.41e-06	CbGpPWpGaD
Bosutinib—FYN—Immune System—HRAS—autistic disorder	1.97e-06	3.39e-06	CbGpPWpGaD
Bosutinib—RPS6KB1—Signaling Pathways—IL6—autistic disorder	1.96e-06	3.38e-06	CbGpPWpGaD
Bosutinib—MAP2K5—Signaling Pathways—IL6—autistic disorder	1.96e-06	3.38e-06	CbGpPWpGaD
Bosutinib—MAP2K1—Immune System—HRAS—autistic disorder	1.96e-06	3.38e-06	CbGpPWpGaD
Bosutinib—EGFR—Disease—MAPK1—autistic disorder	1.96e-06	3.37e-06	CbGpPWpGaD
Bosutinib—PDGFRB—Immune System—IL6—autistic disorder	1.95e-06	3.37e-06	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—PTEN—autistic disorder	1.95e-06	3.36e-06	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—PTEN—autistic disorder	1.94e-06	3.34e-06	CbGpPWpGaD
Bosutinib—MAP2K2—Disease—HRAS—autistic disorder	1.93e-06	3.33e-06	CbGpPWpGaD
Bosutinib—MAP3K7—Signaling Pathways—MAPK1—autistic disorder	1.93e-06	3.33e-06	CbGpPWpGaD
Bosutinib—LYN—Immune System—IL6—autistic disorder	1.91e-06	3.3e-06	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—DHFR—autistic disorder	1.91e-06	3.3e-06	CbGpPWpGaD
Bosutinib—ABL1—Immune System—IL6—autistic disorder	1.9e-06	3.28e-06	CbGpPWpGaD
Bosutinib—ERBB3—Signaling Pathways—IL6—autistic disorder	1.89e-06	3.26e-06	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—SERPINE1—autistic disorder	1.89e-06	3.25e-06	CbGpPWpGaD
Bosutinib—PDGFRB—Disease—HRAS—autistic disorder	1.89e-06	3.25e-06	CbGpPWpGaD
Bosutinib—LCK—Disease—MAPK1—autistic disorder	1.88e-06	3.25e-06	CbGpPWpGaD
Bosutinib—FYN—Immune System—IL6—autistic disorder	1.88e-06	3.25e-06	CbGpPWpGaD
Bosutinib—MAP2K1—Immune System—IL6—autistic disorder	1.87e-06	3.23e-06	CbGpPWpGaD
Bosutinib—EGFR—Signaling by GPCR—HRAS—autistic disorder	1.86e-06	3.21e-06	CbGpPWpGaD
Bosutinib—MAP2K2—Disease—IL6—autistic disorder	1.85e-06	3.19e-06	CbGpPWpGaD
Bosutinib—ABCB1—Metabolism—MTHFR—autistic disorder	1.83e-06	3.15e-06	CbGpPWpGaD
Bosutinib—FYN—Disease—HRAS—autistic disorder	1.82e-06	3.13e-06	CbGpPWpGaD
Bosutinib—MAP2K1—Disease—HRAS—autistic disorder	1.81e-06	3.12e-06	CbGpPWpGaD
Bosutinib—SRC—Immune System—MAPK1—autistic disorder	1.81e-06	3.12e-06	CbGpPWpGaD
Bosutinib—PDGFRB—Disease—IL6—autistic disorder	1.8e-06	3.11e-06	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—IL2—autistic disorder	1.79e-06	3.09e-06	CbGpPWpGaD
Bosutinib—EGFR—Signaling by GPCR—IL6—autistic disorder	1.78e-06	3.07e-06	CbGpPWpGaD
Bosutinib—PTK2—Signaling Pathways—HRAS—autistic disorder	1.76e-06	3.03e-06	CbGpPWpGaD
Bosutinib—FYN—Disease—IL6—autistic disorder	1.74e-06	3e-06	CbGpPWpGaD
Bosutinib—YES1—Signaling Pathways—HRAS—autistic disorder	1.73e-06	2.99e-06	CbGpPWpGaD
Bosutinib—MAP2K1—Disease—IL6—autistic disorder	1.73e-06	2.98e-06	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—IL2—autistic disorder	1.73e-06	2.97e-06	CbGpPWpGaD
Bosutinib—ABCB1—Metabolism—APOE—autistic disorder	1.7e-06	2.93e-06	CbGpPWpGaD
Bosutinib—EGFR—Immune System—HRAS—autistic disorder	1.7e-06	2.93e-06	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling Pathways—MAPK1—autistic disorder	1.69e-06	2.91e-06	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—PTEN—autistic disorder	1.68e-06	2.9e-06	CbGpPWpGaD
Bosutinib—PTK2—Signaling Pathways—IL6—autistic disorder	1.68e-06	2.9e-06	CbGpPWpGaD
Bosutinib—SRC—Disease—MAPK1—autistic disorder	1.67e-06	2.88e-06	CbGpPWpGaD
Bosutinib—YES1—Signaling Pathways—IL6—autistic disorder	1.66e-06	2.86e-06	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—MAPK1—autistic disorder	1.64e-06	2.84e-06	CbGpPWpGaD
Bosutinib—IRAK1—Signaling Pathways—HRAS—autistic disorder	1.64e-06	2.84e-06	CbGpPWpGaD
Bosutinib—LCK—Immune System—HRAS—autistic disorder	1.64e-06	2.83e-06	CbGpPWpGaD
Bosutinib—EGFR—Immune System—IL6—autistic disorder	1.63e-06	2.81e-06	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—PTEN—autistic disorder	1.62e-06	2.8e-06	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—MAPK1—autistic disorder	1.61e-06	2.78e-06	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—MAPK1—autistic disorder	1.59e-06	2.73e-06	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—MAPK1—autistic disorder	1.58e-06	2.72e-06	CbGpPWpGaD
Bosutinib—IRAK1—Signaling Pathways—IL6—autistic disorder	1.57e-06	2.71e-06	CbGpPWpGaD
Bosutinib—EGFR—Disease—HRAS—autistic disorder	1.57e-06	2.71e-06	CbGpPWpGaD
Bosutinib—LCK—Immune System—IL6—autistic disorder	1.57e-06	2.7e-06	CbGpPWpGaD
Bosutinib—MAP3K7—Signaling Pathways—HRAS—autistic disorder	1.55e-06	2.67e-06	CbGpPWpGaD
Bosutinib—ABCB1—Metabolism—PIK3CG—autistic disorder	1.54e-06	2.65e-06	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—IL2—autistic disorder	1.53e-06	2.63e-06	CbGpPWpGaD
Bosutinib—LCK—Disease—HRAS—autistic disorder	1.51e-06	2.61e-06	CbGpPWpGaD
Bosutinib—EGFR—Disease—IL6—autistic disorder	1.5e-06	2.59e-06	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—CYP19A1—autistic disorder	1.5e-06	2.58e-06	CbGpPWpGaD
Bosutinib—MAP3K7—Signaling Pathways—IL6—autistic disorder	1.48e-06	2.56e-06	CbGpPWpGaD
Bosutinib—ABCB1—Metabolism—POMC—autistic disorder	1.46e-06	2.52e-06	CbGpPWpGaD
Bosutinib—SRC—Immune System—HRAS—autistic disorder	1.45e-06	2.5e-06	CbGpPWpGaD
Bosutinib—LCK—Disease—IL6—autistic disorder	1.45e-06	2.5e-06	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—PTEN—autistic disorder	1.44e-06	2.48e-06	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—COMT—autistic disorder	1.39e-06	2.4e-06	CbGpPWpGaD
Bosutinib—SRC—Immune System—IL6—autistic disorder	1.39e-06	2.39e-06	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—GSTP1—autistic disorder	1.39e-06	2.39e-06	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—MAOA—autistic disorder	1.38e-06	2.39e-06	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—MAPK1—autistic disorder	1.37e-06	2.36e-06	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling Pathways—HRAS—autistic disorder	1.35e-06	2.33e-06	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—CAT—autistic disorder	1.35e-06	2.33e-06	CbGpPWpGaD
Bosutinib—SRC—Disease—HRAS—autistic disorder	1.34e-06	2.31e-06	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—HRAS—autistic disorder	1.32e-06	2.28e-06	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—MAPK1—autistic disorder	1.32e-06	2.28e-06	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling Pathways—IL6—autistic disorder	1.29e-06	2.23e-06	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—HRAS—autistic disorder	1.29e-06	2.23e-06	CbGpPWpGaD
Bosutinib—SRC—Disease—IL6—autistic disorder	1.28e-06	2.21e-06	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—GSTM1—autistic disorder	1.27e-06	2.2e-06	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—PLA2G4A—autistic disorder	1.27e-06	2.2e-06	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—HRAS—autistic disorder	1.27e-06	2.19e-06	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—HRAS—autistic disorder	1.27e-06	2.18e-06	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—IL6—autistic disorder	1.26e-06	2.18e-06	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—IL6—autistic disorder	1.24e-06	2.13e-06	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—GPX1—autistic disorder	1.22e-06	2.1e-06	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—IL6—autistic disorder	1.22e-06	2.1e-06	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—IL6—autistic disorder	1.21e-06	2.09e-06	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—MAPK1—autistic disorder	1.17e-06	2.01e-06	CbGpPWpGaD
Bosutinib—ABCB1—Metabolism—PTGS2—autistic disorder	1.17e-06	2.01e-06	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—MTHFR—autistic disorder	1.13e-06	1.94e-06	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—HRAS—autistic disorder	1.1e-06	1.9e-06	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—HRAS—autistic disorder	1.06e-06	1.83e-06	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—IL6—autistic disorder	1.05e-06	1.81e-06	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—APOE—autistic disorder	1.05e-06	1.81e-06	CbGpPWpGaD
Bosutinib—ABCB1—Metabolism—PTEN—autistic disorder	1.02e-06	1.75e-06	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—IL6—autistic disorder	1.01e-06	1.75e-06	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—PIK3CG—autistic disorder	9.46e-07	1.63e-06	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—HRAS—autistic disorder	9.38e-07	1.62e-06	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—POMC—autistic disorder	9.01e-07	1.55e-06	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—IL6—autistic disorder	8.98e-07	1.55e-06	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—PTGS2—autistic disorder	7.18e-07	1.24e-06	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—PTEN—autistic disorder	6.26e-07	1.08e-06	CbGpPWpGaD
